A0828512
Atovaquone , ≥98% , 95233-18-4
Synonym(s):
Atovaquone;Mepron;trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
Pack Size | Price | Stock | Quantity |
250MG | RMB159.20 | In Stock |
|
1G | RMB319.20 | In Stock |
|
5g | RMB1039.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 216-2190C |
Boiling point: | 535.0±50.0 °C(Predicted) |
Density | 1.349±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: >10mg/mL |
pka | 5.01±0.10(Predicted) |
form | powder |
color | yellow |
λmax | 494nm(aq. Buffer)(lit.) |
Merck | 14,866 |
InChIKey | KUCQYCKVKVOKAY-CTYIDZIISA-N |
CAS DataBase Reference | 95233-18-4(CAS DataBase Reference) |
Description and Uses
Atovaquone is an orally active antiprotozoal agent indicated for patients with mild to moderate AIDS-associated Pneumocystis carinii pneumonia who are intolerant to the fist-line therapy of trimethoprim-sulfamethoxazole. It is also under investigation as a treatment for malaria and AIDS-associated toxoplasmosis.
beta-adrenergic blocker